🔗 Share this article

An underground economy for unlicensed weight-loss drugs is propelled by TikTok fitness influencers and sellers on communication apps, according to new investigations.

Investigational Drug Acquiring Popularity Online

The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its supposed fat-burning properties. Viewers are encouraged to message these profiles directly for supplier links, while also receiving discount codes.

Thriving Commerce on Messaging Platforms

Additionally, a flourishing market exists on messaging services, where communities with thousands of members share comparison photos, injection guides and assertions of rapid British shipping. Vendors market the substance there before redirecting buyers to WhatsApp for purchases.

Understanding The Experimental Drug

Retatrutide is an investigational injectable created by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help patients lose up to 25% of their total weight. Nicknamed the “triple G”, the substance is being hailed digitally as the successor to Ozempic.

Medical Experts Voice Concerns

Nevertheless, physicians and pharmacists have warned that the distribution of what remains an unapproved medication in the UK is a cause for concern and could result in users injecting substances of uncertain source.

Some experts said the popularity for retatrutide could be linked to the rising price of licensed weight loss treatments such as Mounjaro.

Legal Position and Enforcement

Marketing the unapproved drug on social media or Telegram is illegal in the UK, as it is an unlicensed drug that must not be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Several influencers attempt to circumvent the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still breach medicines, marketing, and customer laws, potentially leading to penalties, legal action or prison.

Service Reaction and Content Elimination

According to TikTok, the platform has taken down problematic content and prohibited associated hashtags and search suggestions. The organization stated it was committed to maintaining the service secure and investing in strengthening enforcement strategies.

Online Marketplace Activities

Research also discovered communities with up to 9,000 members selling the experimental drug using Telegram's built-in search feature, which operates like a public directory. Entering “retatrutide” immediately displays channels with numerous of members, populated with photos of weight loss, glowing reviews and detailed instructions for mixing or administering at home.

Within moments of joining one group, a vendor posted contact information, where the majority of transactions take place. The vendor provided an guidebook and promised shipping within 48 hours. When questioned whether the product was authentic, one seller said: “You can’t be sure.” Another provided a image of a alleged testing documentation. Not one asked about body mass, health issues or previous experience.

Product Information and Pricing

Inside these communities, messages display black plastic packages with Royal Mail stickers, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at home with purified liquid, or ready-to-use injectors typically sold at 160 pounds for 20mg. When asked how long a pen should last, sellers give contradictory responses ranging from a few weeks to “depends on your body”.

Service Moderation and Security Actions

A spokesperson for the messaging service stated it actively moderated dangerous material on its service including content that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“People are administering materials they can’t verify. Even if the science behind retatrutide is sound, these online products may not include what they advertise,” stated Jason Murphy, the director of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor linked the increase in interest to current cost increases for authorized slimming drugs such as Mounjaro. “With costs rising, patients are turning to online platforms. But counterfeit treatments are highly dangerous. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she said.

Her staff has previously encountered individuals injured by self-injection from unconfirmed sources. “We recognize the disappointment, but purchasing from messaging apps or WhatsApp is taking chances with your health,” stated the doctor. “These substances could be impure or incorrectly dosed.”

Manufacturer Statement

A representative from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been reviewed or approved by any government authority anywhere in the world. “Consequently at this time no one can sell [it] for human use,” they said, noting that any item “misleadingly claiming itself as a Lilly investigational product not yet authorized … may expose patients to possibly significant medical dangers”.